<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Score values of the sixteen computationally predicted pharmacological anti-COVID-19-related activities (against SARS-CoV-2 nsps/sps and human sp ACE2) of the target 1,3,4-oxadiazoles (
   <bold>CoViTris2020</bold> and 
   <bold>ChloViD2020</bold>) and the three reference drugs (remdesivir, ivermectin, and favipiravir), respectively, using COVID-19 Docking Server methodology (the table demonstrates the top docking binding model score value, i.e., the least predicted binding energy value, in kcal/mol for each compound with each target protein)
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" rowspan="2">Classification</th>
    <th align="left" rowspan="2">SARS-CoV-2/Human target protein</th>
    <th align="left" colspan="5">Top pose score value for docking of nCoV protein targets
     <break/>Inhibitory binding energies/affinities (kcal/mol)
    </th>
   </tr>
   <tr>
    <th align="left">
     <bold>CoViTris2020</bold>
    </th>
    <th align="left">
     <bold>ChloViD2020</bold>
    </th>
    <th align="left">
     <bold>Remdesivir</bold>
    </th>
    <th align="left">
     <bold>Ivermectin</bold>
     <break/>(
     <bold>
      <italic>B</italic>
     </bold>
     <sub>
      <bold>
       <italic>1a</italic>
      </bold>
     </sub>
     <bold>
      <italic> form</italic>
     </bold>)
    </th>
    <th align="left">
     <bold>Favipiravir</bold>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="14">
     <italic>Nsps</italic>
    </td>
    <td align="left">Mpro</td>
    <td align="left">− 9.50</td>
    <td align="left">− 8.20</td>
    <td align="left">− 7.70</td>
    <td align="left">− 6.50</td>
    <td align="left">− 5.40</td>
   </tr>
   <tr>
    <td align="left">RdRp (RTP site)</td>
    <td align="left">− 12.00</td>
    <td align="left">− 9.60</td>
    <td align="left">− 8.30</td>
    <td align="left">− 7.10</td>
    <td align="left">− 6.90</td>
   </tr>
   <tr>
    <td align="left">RdRp (RNA site)</td>
    <td align="left">− 9.40</td>
    <td align="left">− 7.90</td>
    <td align="left">− 7.10</td>
    <td align="left">− 6.60</td>
    <td align="left">− 6.10</td>
   </tr>
   <tr>
    <td align="left">PLpro (dimer)</td>
    <td align="left">− 10.60</td>
    <td align="left">− 9.30</td>
    <td align="left">− 8.10</td>
    <td align="left">− 6.00</td>
    <td align="left">− 5.40</td>
   </tr>
   <tr>
    <td align="left">Nsp3 (207-379, AMP site)</td>
    <td align="left">− 9.70</td>
    <td align="left">− 7.70</td>
    <td align="left">− 7.10</td>
    <td align="left">− 5.90</td>
    <td align="left">− 5.40</td>
   </tr>
   <tr>
    <td align="left">Nsp3 (207-379, MES site)</td>
    <td align="left">− 9.90</td>
    <td align="left">− 9.90</td>
    <td align="left">− 8.40</td>
    <td align="left">− 6.40</td>
    <td align="left">− 5.50</td>
   </tr>
   <tr>
    <td align="left">Helicase (ADP site)</td>
    <td align="left">− 8.80</td>
    <td align="left">− 8.00</td>
    <td align="left">− 7.00</td>
    <td align="left">− 5.80</td>
    <td align="left">− 5.30</td>
   </tr>
   <tr>
    <td align="left">Helicase (NCB site)</td>
    <td align="left">− 9.90</td>
    <td align="left">− 8.90</td>
    <td align="left">− 7.50</td>
    <td align="left">− 6.10</td>
    <td align="left">− 5.40</td>
   </tr>
   <tr>
    <td align="left">Nsp14 (ExoN)</td>
    <td align="left">− 8.10</td>
    <td align="left">− 7.50</td>
    <td align="left">− 7.70</td>
    <td align="left">− 5.70</td>
    <td align="left">− 4.90</td>
   </tr>
   <tr>
    <td align="left">Nsp14 (N7-MTase)</td>
    <td align="left">− 11.40</td>
    <td align="left">− 9.30</td>
    <td align="left">− 9.10</td>
    <td align="left">− 7.20</td>
    <td align="left">− 6.10</td>
   </tr>
   <tr>
    <td align="left">Nsp15 (endoribonuclease)</td>
    <td align="left">− 8.50</td>
    <td align="left">− 8.10</td>
    <td align="left">− 8.30</td>
    <td align="left">− 6.00</td>
    <td align="left">− 4.80</td>
   </tr>
   <tr>
    <td align="left">Nsp16 (GTA site)</td>
    <td align="left">− 10.10</td>
    <td align="left">− 8.70</td>
    <td align="left">− 8.30</td>
    <td align="left">− 6.80</td>
    <td align="left">− 5.60</td>
   </tr>
   <tr>
    <td align="left">Nsp16 (MGP site)</td>
    <td align="left">− 9.70</td>
    <td align="left">− 7.70</td>
    <td align="left">− 7.30</td>
    <td align="left">− 6.20</td>
    <td align="left">− 5.10</td>
   </tr>
   <tr>
    <td align="left">Nsp16 (SAM site)</td>
    <td align="left">− 10.10</td>
    <td align="left">− 8.70</td>
    <td align="left">− 8.10</td>
    <td align="left">− 6.70</td>
    <td align="left">− 5.50</td>
   </tr>
   <tr>
    <td align="left" rowspan="2">
     <italic>Sps</italic>
    </td>
    <td align="left">N protein (NCB site)</td>
    <td align="left">− 10.00</td>
    <td align="left">− 8.90</td>
    <td align="left">− 7.40</td>
    <td align="left">− 6.50</td>
    <td align="left">− 5.20</td>
   </tr>
   <tr>
    <td align="left">Human ACE2</td>
    <td align="left">− 10.20</td>
    <td align="left">− 9.00</td>
    <td align="left">− 7.90</td>
    <td align="left">− 6.70</td>
    <td align="left">− 5.60</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
